IQVIA™ Real-World Insights Bibliography

REAL WORLD OUTCOMES OF ADJUVANTED TRIVALENT INFLUENZA VACCINE COMPARED TO FLUZONE-HD AND EGG-BASED QUADRIVALENT AND TRIVALENT VACCINES AMONG THE US ELDERLY DURING 2016-2018 FLU SEASONS USING CLAIMS DATA
Author(s): Victoria Divino, Joaquin Mould-Quevedo, Miao Jiang, Mitchell DeKoven, Girishanthy Krishnarajah
Affiliations(s): IQVIA; Seqirus
Publication(s):  Conference. Options X for the Control of Influenza. Singapore, 28 August - 1 September 2019
Document Type(s): Poster,
Countries: USA,
C:
Y:
Immunology and Vaccination, Respiratory disease,
2019
  L:
A:
English
Retrospective database analysis,
  Add to report
 
 
HOSPITALIZATION ENCOUNTERS FOLLOWING VACCINATION WITH ADJUVANTED TRIVALENT INFLUENZA VACCINE COMPARED TO FLUZONE-HD AND EGG-BASED QUADRIVALENT AND TRIVALENT VACCINES AMONG THE US ELDERLY USING CLAIMS DATA
Author(s): Victoria Divino, Joaquin Mould-Quevedo, Mitchell DeKoven, Miao Jiang, Girishanthy Krishnarajah
Affiliations(s): IQVIA; Seqirus
Publication(s):  Conference. Options X for the Control of Influenza. Singapore, 28 August - 1 September 2019
Document Type(s): Poster,
Countries: USA,
C:
Y:
Immunology and Vaccination, Respiratory disease,
2019
  L:
A:
English
Retrospective database analysis,
  Add to report
 
 
Lessons learned on enhanced passive safety surveillance of influenza vaccines.
Author(s): Khalife N., Almas M, Stam Morago, M, Negreiro F, Costa L, Projetto, S
Affiliations(s): 
Publication(s):  Pharmacoepidemiol & Drug Saf 2018;27(2):495
Document Type(s): Poster,
Countries: 
C:
Y:
Immunology and Vaccination,
2018
  L:
A:
English
  Add to report
 
 
Observational safety study of specific outcomes after trivalent cell culture seasonal influenza vaccination (Optaflu® ) among adults in THIN database of electronic UK primary healthcare records
Author(s): Hall GC, Davies PTG, Karim MY, Haag MDM & O'Leary C
Affiliations(s): Seqirus
Publication(s):  Pharmacoepidemiology and Drug Safety
Document Type(s): Article,
Countries: UK,
C:
Y:
Immunology and Vaccination,
2018
  L:
A:
English
Retrospective database analysis,
  Add to report
 
 
Epidemiologic and economic burden of HPV diseases in Spain: implication of additional 5 types from the 9-valent vaccine.
Author(s): López N1, Torné A2, Franco A3, San-Martin M1, Viayna E4, Barrull C4, Perulero N4.
Affiliations(s): 1Medical Affairs, MSD, Madrid, Spain.22Gynecologic Oncology Unit, Institut Clinic of Gynecology, Obstetrics and Neonatology (ICGON), Hospital Clínic-Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Faculty of Medicine, University of Barcelona, Barcelona, Spain.33Diagnostic Unit of Urology, Clinic Institute of Nephrology and Urology (ICNU) Hospital Clínic Barcelona, University of Barcelona, Barcelona, Spain.4Health Economics and Outcomes Research, Real World Insights, IQVIA, Barcelona, Spain.
Publication(s):  Infect Agent Cancer. 2018 May 2;13:15.
Document Type(s): Article,
Countries: Spain,
Click here for the abstract
C:
Y:
Health economics, Immunology and Vaccination, Infectious disease, Oncology,
2018
  L:
A:
English
Burden of illness, clinical setting: Secondary care, Literature Review, Review, Survey research,
  Add to report
 
 
The economic burden of CIDP in the United States: A case-control study.
Author(s): Divino V, Mallick R, DeKoven M, Krishnarajah G
Affiliations(s): IQVIA; CLS Behring
Publication(s):  Journal. PLoS One. 2018 Oct 23;13(10):e0206205.
Document Type(s): Article,
Countries: USA,
Click here for the abstract
C:
Y:
Immunology and Vaccination,
2018
  L:
A:
English
Cost of illness, Retrospective database analysis,
  Add to report
 
 
Predictors and diseasburden of ulcerative colitis progression in Sweden.
Author(s): Stålhammar J1,Hällström P1, Agreus L2, Beydogan H3, Arnheim Dahlström L3, Skup M4, Lee W-J4
Affiliations(s): 1 Uppsala University, Uppsala, Sweden 2 Karolinska Institutet, Stockholm, Sweden 3 QuintilesIMS, Stockholm, Sweden 4 AbbVie Inc., North Chicago, USA.
Publication(s):  UEG Barcelona September 2017
Document Type(s): Abstract,
Countries: Sweden,
C:
Y:
Immunology and Vaccination,
2017
  L:
A:
English
Retrospective cohort analysis,
  Add to report
 
 
Market share and switching dynamics between Etanercept and its biosimilar product in Sweden and Germany: a real-world preliminary analysis.
Author(s): Alten R1, Neregård P2, Jones HE3, Meng T4, Curiale C5, Singh E6, Lucchese L7, Gossen N8, Bergman GJ9, Miglio C7
Affiliations(s): 1 Shlosspark-Klinik Teaching Hospital of the Charité, Berlin, Germany 2 Pfizer, Sollentuna, Sweden 3 Pfizer inc., Collegeville, PA, USA 4 Pfizer Pharma GmbH, Berlin, Germany 5 Pfizer, Rome, Italy 6 Pfizer Inc., Collegeville, PA, USA 7 QuintilesIMS, London, UK 8 QuintilesIMS, Frankfurt, Germany 9 QuintilesIMS, Solna, Sweden
Publication(s):  ISPOR 20th Annual European Congress
Document Type(s): 
Countries: Germany, Sweden,
Click here for the abstract
C:
Y:
Immunology and Vaccination, Patient Registries & Real-World Study Methods, Rheumatology,
2017
  L:
A:
English
Retrospective database analysis,
  Add to report
 
 
Compliance with vaccination against hepatitis A virus in Germany: a retrospective analysis
Author(s): Jacob L, Kostev K
Affiliations(s): 
Publication(s):  Int J Clin Pharmacol Ther. 2017 Jul 24. doi: 10.5414/CP202990. [Epub ahead of print]
Document Type(s): Article,
Countries: Germany,
C:
Y:
Immunology and Vaccination,
2017
  L:
A:
English
Retrospective cohort analysis,
  Add to report
 
 
Compliance with vaccination against tick-borne encephalitis virus in Germany
Author(s): Jacob L, Kostev K
Affiliations(s): 
Publication(s):  Clin Microbiol Infect. 2017 Jan 28. pii: S1198-743X(17)30045-9. doi: 10.1016/j.cmi.2017.01.012. [Epub ahead of print]
Document Type(s): Article,
Countries: Germany,
C:
Y:
Immunology and Vaccination,
2017
  L:
A:
English
  Add to report
 
 
 1 of 7 Next Page Last Page